ENTITY

RenovoRx Inc (RNXT US)

1
Analysis
Health CareUnited States
RenovoRx, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing therapies for the local treatment of solid tumors and for targeted chemotherapy delivery for pancreatic cancer patients. RenovoRx serves customers in the United States.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x